Large employers fear vaccine mandates will chase away workers. But 'real world data tells a different story.'


As COVID-19 vaccine mandates roll out across federal agencies and among many private businesses, companies that fall under the Biden administration's vaccine-or-test requirement are worried about employees quitting, a new poll has found.
President Biden directed the Labor Department to develop a rule that companies with 100+ employees must require proof of vaccination or weekly negative test results. It hasn't taken effect yet, but many of those employers told the Society for Human Resource Management they're worried it will lead to lots of resignations, reports The Hill.
"Nearly 9 in 10 large employers believe some of their workers will quit their jobs over the Biden administration's coronavirus vaccine-or-test mandate," writes The Hill. Some are worried about general workplace disruption, while others are concerned about the cost of acquiring rapid COVID-19 tests. Two-thirds of those surveyed said they could not afford to pay for weekly testing.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fears that employees will quit en masse or move to smaller companies not affected by the rule are understandable, but other data doesn't point to the worries being warranted. As The Hill writes, "real world data tells a different story," pointing to United Airlines announcing layoffs of 230 employees who didn't comply with vaccine requirements — 0.3 percent of its workforce. Similarly, 58 percent of those surveyed in a September Morning Consult poll supported the Biden administration's vaccine mandate for large companies.
The Society for Human Resource Management surveyed 1,289 of its members online between Sept. 27-30. Read more at The Hill.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?
The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy